[HTML][HTML] Global changing trends in incidence and mortality of gastric cancer by age and sex, 1990-2019: Findings from Global Burden of Disease Study

T Zhang, H Chen, Y Zhang, X Yin, J Man, X Yang… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background: The global disease burden of gastric cancer (GC) is still heavy. Understanding
the patterns and trends of the global GC burden is important for developing precise …

[HTML][HTML] Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β

LJ Chen, L Wu, W Wang, LL Zhai… - International …, 2022 - spandidos-publications.com
Pancreatic cancer (PC) is a lethal type of cancer for which effective therapies are limited.
Long non‑coding RNAs (lncRNAs) represent a critical type of regulator category, mediating …

[HTML][HTML] Cutaneous manifestations in pancreatic diseases—a review

R Miulescu, DV Balaban, F Sandru… - Journal of Clinical …, 2020 - mdpi.com
Pancreatic pathology, comprising acute and chronic pancreatitis, autoimmune pancreatitis
and pancreatic neoplasms, primarily presents with gastrointestinal symptoms and signs; …

A Multilayer Perceptron Neural Network Model to Classify Hypertension in Adolescents Using Anthropometric Measurements: A Cross‐Sectional Study in Sarawak …

SS Chai, WL Cheah, KL Goh… - … Methods in Medicine, 2021 - Wiley Online Library
This study outlines and developed a multilayer perceptron (MLP) neural network model for
adolescent hypertension classification focusing on the use of simple anthropometric and …

[HTML][HTML] Radiotherapy in pancreatic cancer: to whom, when, and how?

M Falco, B Masojć, T Sulikowski - Cancers, 2023 - mdpi.com
Simple Summary The prognosis of pancreatic cancer is always serious. In most cases, the
cancer is diagnosed at an advanced stage. The treatment is based on the combination of …

[HTML][HTML] Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives

E Koustas, EM Trifylli, P Sarantis… - International Journal of …, 2022 - mdpi.com
Gastrointestinal (GI) cancer constitutes a highly lethal entity among malignancies in the last
decades and is still a major challenge for cancer therapeutic options. Despite the current …

[HTML][HTML] Hypoxia, a targetable culprit to counter pancreatic cancer resistance to therapy

R Abou Khouzam, JM Lehn, H Mayr, PA Clavien… - Cancers, 2023 - mdpi.com
Simple Summary Hypoxia is a key feature of the tumor microenvironment involved in the
pathogenesis of pancreatic ductal adenocarcinoma (PDAC). In this review we will highlight …

Metabolomics study reveals systematic metabolic dysregulation and early detection markers associated with incident pancreatic cancer

S Wang, M Li, L Yan, M He, H Lin, Y Xu… - … journal of cancer, 2022 - Wiley Online Library
Biomarkers for early detection of pancreatic cancer are in urgent need. To explore
systematic circulating metabolites unbalance and identify potential biomarkers for pancreatic …

Targeting mitochondrial dysfunctions in pancreatic cancer evokes new therapeutic opportunities

A Sarwar, M Zhu, Q Su, Z Zhu, T Yang, Y Chen… - Critical Reviews in …, 2022 - Elsevier
Pancreatic cancer (PC) is a highly devastating neoplasm due to its irrepressible
characteristics and propensity to override the available treatment strategies. Rapid …

[HTML][HTML] The role of endoscopic ultrasonography in the diagnosis and staging of pancreatic cancer

A Zakaria, B Al-Share, JB Klapman, A Dam - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic cancer ranks as the seventh leading cause of cancer-related
death worldwide. The overall prognosis of pancreatic cancer is poor even in patients with …